Abstract
Chronic venous disease (CVD) is a common venous disease of the lower extremities and patients often develop symptoms of itching and skin roughness. An easy to use and objective skin examination was recently developed that allows measurement of the level of stratum corneum content and transepidermal water loss (TEWL), which can indicate the status of the barrier function of the stratum corneum. Previous studies demonstrated that histamine production from mast cells, and tryptase and matrix metalloprotease-9 levels were associated with skin inflammation. This study aimed to clarify the relationship between dry skin and inflammatory mediators that mediate the skin symptoms of CVD subjects. The study enrolled 27 subjects with CVD and a control group consisting of 9 volunteers. The itching onset frequency was higher in women (70.4%) compared with men (50.0%). To analyze the mechanisms involved in itching we measured blood inflammatory mediators pre- and post-sclerotherapy. There was a significant decrease in Substance P, histamine, IgE, and tryptase levels post-sclerotherapy compared with those at pre-sclerotherapy. These levels were associated with the severity of itching. In addition, compared with the control subjects, there was a significant increase in the stratum corneum water content and a decrease in the TEWL in the 27 patients with CVD. This was associated with a decrease in the itching symptoms. Our findings indicate that sclerotherapy decreased levels of inflammatory mediators, increased stratum corneum water content and decreased TEWL, which coincided with reduced itching in CVD patients, indicating they might be therapeutic targets.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00403-017-1721-8/MediaObjects/403_2017_1721_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00403-017-1721-8/MediaObjects/403_2017_1721_Fig2_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00403-017-1721-8/MediaObjects/403_2017_1721_Fig3_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00403-017-1721-8/MediaObjects/403_2017_1721_Fig4_HTML.gif)
Similar content being viewed by others
References
Asanuma K, Magid R, Johnson C, Nerem RM, Galis ZS (2003) Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol 284:H1778–H1784
Bartholomew JR, King T, Avisesh S, Vidimos AT (2005) Varicose veins: newer, better treatments available. Cleve Clin J Med 72:312–314 (319–321, 325–328)
Beebe HG, Bergan JJ, Bergqvist D et al (1996) Classification and grading of chronic venous disease in the lower limbs: a consensus statement. Eur J Vasc Endovasc Surg 12:487–491
Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D (2005) The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 15:175–184
Bergan JJ, Schmid-Schonbein GW, Smith PDC, Nicolaides AN, Boisseau MR, Eklof B (2006) Mechanism of disease: chronic venous disease. N Eng J Med 355:488–498
Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FG (1999) What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ 318:353–356
Eberlein-König B, Schäfer T, Huss-Marp J, Darsow U, Möhrenschlager M, Herbert O, Abeck D, Krämer U, Behrendt H, Ring J (2000) Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol 80(3):188–191
Eklof B, Rutherford RB, Bergan JJ Carpentier PH, Gloviczki P, Kistner RL, Meissner MH, Moneta GL, Myers K, Padberg FT, Perrin M, Ruckley CV, Smith PC, Wakefieid TW (2004) Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 40:1248–1252
Fisher GJ, Wang ZQ, Datta SC, Varani J, Kang S, Voorhees JJ (1997) Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 337:1419–1428
Fjellner B, Hagermark O (1981) Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol 61:245–250
Hagermark O, Hokfelt T, Pernow B (1978) Flare and itch induced by substance P in human skin. J Invest Dermatol 71:233–235
Hosogi M, Schmelz M, Miyachi Y, Ikoma A (2006) Bradykinin is a potent pruritogen in atopic dermatitis: a switch from pain to itch. Pain 126:16–23
Iddamalgoda A, Le QT, Ito K, Tanaka K, Kojima H, Kido H (2008) Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Arch Dermatol Res 300:S69–S76
Kikuchi K, Kobayashi H, Le Fur I, Tschachler E, Tagami H (2002) The winter season affects more severely the facial skin than the forearm skin: comparative biophysical studies conducted in the same Japanese females in later summer and winter. Exog Dermatol 1:32–38. doi:10.1159/000047989
Kinet JP (1999) The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17:931–972
Knor T, Meholjić-Fetahović A, Mehmedagić A (2011) Stratum corneum hydration and skin surface pH in patients with atopic dermatitis. Acta Dermatovenerol Croat 19:242–247
Kohno K, Niihara H, Hamano T, Takeda M, Yamasaki M, Mizumoto K, Nabika T, Morita E, Shiwaku K (2014) Standing posture at work and overweight exacerbate varicose veins: Shimane CoHRE Study. J Dermatol 41:964–968
Leknes SG, Bantick S, Willis CM, Wilkinson JD, Wise RG, Tracey I (2007) Itch and motivation to scratch: an investigation of the central and peripheral correlates of allergen- and histamine-induced itch in humans. J Neurophysiol 97:15–22
Milkiewicz M, Haas TL (2005) Effect of mechanical stretch on HIF-1α and MMP-2 expression in capillaries isolated from overloaded skeletal muscles: laser capture microdissection study. Am J Physiol Heart Circ Physiol 289:H1315–H1320
Peters EM, Ericson ME, Hosoi J, Seiffert K, Hordinsky MK, Ansel JC, Paus R, Scholzen TE (2006) Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J Investig Dermatol 126:1937–1947
Schmid-Schönbein GW, Takase S, Bergan JJ (2001) New advances in the understanding of the pathophysiology of chronic venous insufficiency. Angiology 52:S27–S34
Toyoda M, Makino T, Kagoura M, Morohashi M (2000) Immunolocalization of substance P in human skin mast cells. Arch Dermatol Res 292:418–421
Yokoyama S, Hiramoto K, Koyama M, Ooi K (2015) Impaired skin barrier function in mice with colon carcinoma induced by azoxymethane and dextran sodium sulfate. Biol Pharm Bull 38:947–950
Zhou D, Lee HS, Villarreal F, Teng A, Lu E, Reynolds S, Qin C, Smith J, Sung KL (2005) Differential MMP-2 activity of ligament cells under mechanical stretch injury: an in vitro study on human ACL and MCL fibroblasts. J Orthop Res 23:949–957
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in the study involving human participants were in accordance with the ethical standards of the Bioethical Committee of Mie Heart Center and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Takai, Y., Hiramoto, K., Nishimura, Y. et al. Relationship between biochemical factors and skin symptoms in chronic venous disease. Arch Dermatol Res 309, 253–258 (2017). https://doi.org/10.1007/s00403-017-1721-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-017-1721-8